International Psoriasis Council

Advancing Knowledge. Improving Care.

Joke

Borzée

,

MBE

Vlerick Business School
Ghent
,
Belgium
Joke Borzée is a PhD student in Business Economics at Katholieke Universiteit (KU) Leuven and Vlerick Business School, Belgium. She holds a master’s degree in business economics from the Faculty of Business and Economics at KU Leuven. Currently affiliated with the Department of Operations Management, Joke researches the application of optimization techniques in various healthcare settings, aiming to enhance clinical processes and patient experiences. She is particularly interested in the Value-Based Healthcare framework and explores methods for measuring individual patient value to maximize overall value creation.
Last Updated:
08/11/2024

What's New

First-Line Biologics in Psoriasis: Evidence from the BADBIR Cohort Study

In this IPC commentary, Matias Maskin examines evidence from the BADBIR registry demonstrating that first-line biologic therapy in moderate to severe psoriasis leads to faster skin clearance, improved quality of life, and a lower risk of comorbidities. The analysis challenges traditional step-up approaches and supports earlier, patient-centered treatment strategies.

Read More »

Recent Advances in Psoriasis: A Year in Review

In this Take Ten with IPC video, Dr. Leandro Leite discusses the most recent advances in psoriasis over the last year (March 2025 – March 2026). Topics include new guidelines, research, and recent studies.

WATCH NOW

Monday, April 6, 2026